Miscellaneous	O
Proteins	O

Apart	O
from	O
the	O
above	O
-	O
described	O
proteins	O
,	O
several	O
other	O
molecules	O
are	O
also	O
associated	O
with	O
the	O
pathological	B-Pathological_formation
lesions	I-Pathological_formation
of	O
AD	O
,	O
and	O
some	O
of	O
these	O
can	O
be	O
regarded	O
as	O
amateur	O
chaperones	O
.	O

Acute	O
phase	O
proteins	O
,	O
such	O
as	O
alpha1	O
-	O
antichymotrypsin	O
(	O
ACT	O
)	O
,	O
alpha2	O
-	O
macroglobulin	O
(	O
alpha2M	O
)	O
,	O
and	O
SAP	O
,	O
are	O
all	O
associated	O
with	O
Abeta	O
deposition	O
[	O
129	O
-	O
132	O
]	O
.	O

ACT	O
is	O
a	O
serine	O
protease	O
inhibitor	O
of	O
the	O
serpin	O
family	O
,	O
and	O
in	O
AD	O
,	O
ACT	O
levels	O
are	O
upregulated	O
,	O
and	O
binding	O
of	O
ACT	O
with	O
Abeta	O
induces	O
Abeta	O
fibrillogenesis	O
[	O
133	O
-	O
135	O
]	O
.	O

Furthermore	O
,	O
when	O
ACT	O
is	O
overexpressed	O
in	O
transgenic	O
mice	O
,	O
an	O
increased	O
plaque	B-Pathological_formation
load	O
in	O
the	O
brains	B-Organ
of	O
these	O
mice	O
and	O
impaired	O
spatial	O
learning	O
is	O
observed	O
[	O
134	O
,	O
135	O
]	O
.	O

alpha2M	O
also	O
binds	O
Abeta	O
,	O
although	O
in	O
contrast	O
to	O
ACT	O
,	O
this	O
binding	O
prevents	O
Abeta	O
fibril	B-Cellular_component
formation	O
and	O
fibril	B-Cellular_component
-	O
associated	O
neurotoxicity	O
[	O
136	O
,	O
137	O
]	O
.	O

alpha2M	O
promotes	O
the	O
protease	O
-	O
mediated	O
degradation	O
of	O
alpha2M	O
/	O
Abeta	O
complexes	O
and	O
contributes	O
to	O
clearance	O
of	O
Abeta	O
from	O
the	O
brain	B-Organ
(	O
discussed	O
in	O
paragraph	O
4	O
)	O
[	O
138	O
,	O
139	O
]	O
.	O

The	O
glycoprotein	O
SAP	O
belongs	O
to	O
the	O
pentraxin	O
family	O
and	O
is	O
a	O
common	O
component	O
of	O
all	O
known	O
types	O
of	O
amyloid	B-Cellular_component
fibrils	I-Cellular_component
.	O

SAP	O
is	O
upregulated	O
in	O
AD	O
and	O
protects	O
amyloid	B-Cellular_component
fibrils	I-Cellular_component
from	O
proteolysis	O
in	O
vitro	O
[	O
140	O
,	O
141	O
]	O
.	O

SAP	O
not	O
only	O
colocalizes	O
with	O
SPs	O
and	O
interacts	O
with	O
aggregated	O
Abeta	O
;	O
SAP	O
oligomers	O
also	O
bind	O
and	O
activate	O
C1	O
[	O
142	O
]	O
.	O

Both	O
C1	O
and	O
SAP	O
may	O
bind	O
to	O
fibrillar	B-Cellular_component
Abeta	O
deposits	O
in	O
vivo	O
and	O
induce	O
microglial	B-Cell
activation	O
,	O
as	O
cultured	O
human	O
microglial	B-Cell
cells	I-Cell
show	O
an	O
increase	O
in	O
cytokine	O
production	O
after	O
co	O
-	O
stimulation	O
of	O
Abeta	O
with	O
C1q	O
and	O
SAP	O
[	O
104	O
]	O
.	O

These	O
observations	O
further	O
strengthen	O
the	O
above	O
-	O
noted	O
suggestion	O
that	O
not	O
only	O
Abeta	O
,	O
but	O
also	O
several	O
Abeta	O
-	O
binding	O
proteins	O
,	O
are	O
capable	O
of	O
activating	O
the	O
complement	O
system	O
,	O
and	O
thus	O
,	O
contribute	O
to	O
neuroinflammation	O
in	O
AD	O
.	O

In	O
addition	O
,	O
both	O
alpha2M	O
and	O
ACT	O
,	O
in	O
contrast	O
to	O
SAP	O
,	O
can	O
be	O
regarded	O
as	O
amateur	O
chaperones	O
,	O
as	O
they	O
regulate	O
conformational	O
changes	O
of	O
Abeta	O
.	O

Tissue	O
-	O
type	O
plasminogen	O
activator	O
(	O
tPA	O
)	O
regulates	O
activation	O
of	O
plasminogen	O
into	O
plasmin	O
and	O
is	O
expressed	O
in	O
various	O
regions	O
of	O
the	O
brain	B-Organ
especially	O
in	O
the	O
hippocampus	B-Multi-tissue_structure
[	O
143	O
]	O
.	O

Several	O
reports	O
suggested	O
an	O
important	O
role	O
for	O
tPA	O
in	O
AD	O
,	O
as	O
the	O
tPA	O
system	O
is	O
involved	O
in	O
Abeta	O
turnover	O
[	O
144	O
,	O
145	O
]	O
.	O

Fibrillar	B-Cellular_component
forms	O
of	O
Abeta	O
stimulate	O
tPA	O
activity	O
in	O
vitro	O
,	O
whereas	O
in	O
AD	O
patients	O
,	O
a	O
reduction	O
of	O
tPA	O
activity	O
is	O
observed	O
in	O
the	O
affected	O
areas	O
[	O
144	O
,	O
146	O
]	O
.	O

Although	O
tPA	O
has	O
no	O
effect	O
on	O
conformational	O
changes	O
of	O
Abeta	O
,	O
it	O
might	O
play	O
a	O
role	O
in	O
the	O
clearance	O
of	O
Abeta	O
from	O
the	O
brain	B-Organ
(	O
paragraph	O
4	O
]	O
.	O

The	O
actin	O
-	O
regulatory	O
protein	O
gelsolin	O
is	O
found	O
both	O
intracellularly	B-Cell
and	O
in	O
plasma	B-Organism_substance
[	O
147	O
,	O
148	O
]	O
.	O

Plasma	B-Organism_substance
gelsolin	O
can	O
be	O
considered	O
an	O
amateur	O
chaperone	O
,	O
as	O
it	O
binds	O
Abeta	O
and	O
not	O
only	O
inhibits	O
its	O
Abeta	O
fibrillization	O
but	O
is	O
also	O
capable	O
of	O
degrading	O
preformed	O
Abeta	O
fibrils	B-Cellular_component
[	O
149	O
,	O
150	O
]	O
.	O

Furthermore	O
,	O
gelsolin	O
inhibits	O
Abeta	O
-	O
mediated	O
neurotoxicity	O
[	O
151	O
]	O
.	O

One	O
of	O
the	O
major	O
gangliosides	O
in	O
the	O
brain	B-Organ
is	O
GM1	O
.	O

Soluble	O
Abeta	O
binds	O
GM1	O
and	O
the	O
formed	O
complexes	O
accelerate	O
Abeta	O
fibrillogenesis	O
by	O
acting	O
as	O
a	O
seed	O
for	O
Abeta	O
[	O
152	O
]	O
.	O

In	O
the	O
presence	O
of	O
GM1	O
,	O
Abeta	O
is	O
more	O
neurotoxic	O
than	O
Abeta	O
alone	O
,	O
and	O
cholesterol	O
-	O
rich	O
membranes	B-Cellular_component
demonstrate	O
accelerated	O
Abeta	O
binding	O
due	O
to	O
the	O
formation	O
of	O
GM1	O
clusters	O
[	O
153	O
,	O
154	O
]	O
.	O

As	O
GM1	O
is	O
a	O
major	O
component	O
of	O
lipid	B-Organism_substance
rafts	I-Organism_substance
and	O
recent	O
studies	O
suggest	O
that	O
Abeta	O
accumulation	O
in	O
these	O
lipid	B-Organism_substance
rafts	I-Organism_substance
is	O
an	O
early	O
event	O
in	O
AD	O
development	O
,	O
GM1	O
might	O
play	O
an	O
important	O
role	O
in	O
the	O
early	O
steps	O
in	O
AD	O
pathogenesis	O
[	O
155	O
,	O
156	O
]	O
.	O

In	O
summary	O
,	O
several	O
proteins	O
are	O
associated	O
with	O
Abeta	O
aggregates	O
in	O
the	O
AD	B-Organ
brain	I-Organ
and	O
contribute	O
to	O
the	O
aggregation	O
of	O
Abeta	O
and	O
should	O
,	O
therefore	O
,	O
be	O
considered	O
as	O
amateur	O
chaperones	O
.	O

In	O
addition	O
,	O
they	O
might	O
play	O
a	O
role	O
in	O
triggering	O
inflammation	O
.	O

